Attention Deficit Hyperactivity Disorder (ADHD) Policy

ADHD & Stimulant Medication Policy /Comprehensive Plan

  1. Attention Deficit Hyperactivity Disorder (ADHD) is a developmental disorder that commonly presents initially during childhood and is characterized by developmentally atypical levels of inattention and/or hyperactive-impulsive behavior. To be diagnosed with ADHD, these symptoms must have started in childhood, and cause impairment in two or more major life activities, such as interpersonal relations, educational or occupational goals, and/or cognitive or adaptive functioning.  There is no simple definitive test for the disorder. CAPS does not provide ADHD evaluations, or ADHD testing, but will assist students in identifying community resources. Professionals providing testing should consult the documentation guidelines listed on the Accessible NU website.
  2. Treatment for ADHD includes individual therapy and behavioral strategies to improve functioning. Medication may also be helpful. CAPS will assist students in identifying community providers as most interventions do not fit CAPS’ brief therapy model.
  3. CAPS recommends that students with diagnosed ADHD consider registering with Accessible NU and consult their staff about possible accommodations.
  4. In response to a national epidemic of abuse of controlled substances, students receiving prescriptions for stimulant medication from CAPS are asked to sign “CAPS Stimulant Medication Agreement”, for compliance with IL and federal laws. Lost or stolen prescriptions will not be replaced. Periodic urine drug screening may occur. Controlled medications are potentially lethal, and giving or selling medications to others is against the law.
  5. Incoming students with ADHD or suspected ADHD are invited to review CAPS’ Welcome Newsletter for ADHD.
  6. Undergraduate Academic Resources:
  7. Resources by School: